LOS ANGELES, CA--(Marketwire - Dec 15, 2011) - [ Universal Detection Technology ] ([ www.udetection.com ]) (OTCBB: [ UNDT ]), a developer of early-warning monitoring technologies that protect against [ biological ], chemical, and [ radiological threats ], announced today that that it has received a purchase order from the US Army for its biological detection equipment.

A report released by the WMD Center released in October found that the United States is unprepared for a large-scale [ biological attack ], despite spending more than $65 billion on [ biodefense ] over the past decade. The report warned that the threat of biological weapons is now greater than ever as a result of technological advances: "A small team of individuals with training in key disciplines can produce the type of bioweapons created by nation-states in the 1960s."

"We are very pleased to supply our armed forces with the tools to detect [ agents of Bioterror ] such as [ Anthrax ] and Ricin," said Mr. Jacques Tizabi, UNDT's Chairman and CEO. "We understand that, unfortunately, the threat posed by Biological weapons is very dangerous to the government and the civilian sectors," he added.

For more product information please email [ sales@udetection.com ].

For more information please visit our website at [ www.udetection.com ].

About Universal Detection Technology

Universal Detection Technology (UNDT) is a developer of monitoring technologies, including chemical, biological, radiological, nuclear (CBRN), and mold detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. The Company is a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and chemical agent detectors. For more information, please visit [ www.udetection.com ].

Forward Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.